by @dministrator | Aug 8, 2018 | NevakarInjectables
Bridgewater, NJ, AUGUST 8, 2018 – Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered into an exclusive licensing agreement with Endo International plc’s...
by @dministrator | Jun 16, 2017 | NevakarInjectables
Dr. Puri’s first venture, InnoPharma, was founded in 2005 with a focus on developing complex generic pharmaceuticals of sterile injectable dose forms. This was sold to Pfizer in 2014. Puri went on to found Nevakar, which is a specialty pharmaceutical company,...
by @dministrator | Jul 27, 2016 | NevakarInjectables
BRIDGEWATER, NJ, July 27, 2016 – Nevakar LLC, a privately-held specialty pharmaceutical company developing innovative products focused on therapies within the injectable and ophthalmic space, today announced that it has raised $55 million. Proceeds from the financing...
by @dministrator | Jun 12, 2015 | NevakarInjectables
You previously had great success with InnoPharma, which was eventually sold to Pfizer. Could you provide some insight into your new venture, Nevakar? InnoPharma’s acquisition was a strategic move by Pfizer; its product pipeline and track record of successfully...
Recent Comments